News & Analysis on Clinical Trial Services & Contract Research And Development
The World Health Organisation (WHO) has revealed details of a 'super strain' of tuberculosis, which is not only resistant to first choice treatment drugs, but also three or more of the six classes of second-line drugs.
Danish biopharmaceutical firm Bavarian Nordic has received approval from Denmark's government to begin large-scale commercial production of smallpox vaccine based on its Modified Vaccinia Ankara (MVA) virus strain which demonstrates superior safety.
Compounds in cranberry juice may provide a viable alternative to antibiotics that treat urinary tract infections (UTI's) especially for combating E. coli bacteria that have become resistant to conventional treatment.
The world's most prescribed product for chronic obstructive pulmonary disease (COPD) could soon be formulated with a new propellant-free device following an observational study on a soft mist inhaler (SMI) that Boehringer Ingelheim plans to use with...
As the bio-outsourcing market hits boom time, the number of contract biomanufacturing organisations (CBMOs) that specialise in the production of biopharma products, is rapidly expanding.
Workers at a Rhodia specialty chemicals plant in South Carolina are sighing with relief after a fire that broke out in the passing of tropical storm Ernesto was put out before igniting ethanol and pentane in a general processing unit.